Changes
On April 26, 2022 at 1:55:24 PM UTC, Towera:
-
No fields were updated. See the metadata diff for more details.
f | 1 | { | f | 1 | { |
2 | "author": "", | 2 | "author": "", | ||
3 | "author_email": "", | 3 | "author_email": "", | ||
4 | "creator_user_id": "0124c449-4279-4839-a7e2-f7ee873dbc7c", | 4 | "creator_user_id": "0124c449-4279-4839-a7e2-f7ee873dbc7c", | ||
5 | "groups": [ | 5 | "groups": [ | ||
6 | { | 6 | { | ||
7 | "description": "Group for publications", | 7 | "description": "Group for publications", | ||
8 | "display_name": "Publication", | 8 | "display_name": "Publication", | ||
9 | "id": "816c3c41-f871-427d-9e26-fb21e6b3c578", | 9 | "id": "816c3c41-f871-427d-9e26-fb21e6b3c578", | ||
10 | "image_display_url": | 10 | "image_display_url": | ||
11 | mw/uploads/group/2022-03-17-123757.433896243660articlesquareicon.png", | 11 | mw/uploads/group/2022-03-17-123757.433896243660articlesquareicon.png", | ||
12 | "name": "publication", | 12 | "name": "publication", | ||
13 | "title": "Publication" | 13 | "title": "Publication" | ||
14 | } | 14 | } | ||
15 | ], | 15 | ], | ||
16 | "id": "392167b0-d865-4262-b070-c0b0e45b721b", | 16 | "id": "392167b0-d865-4262-b070-c0b0e45b721b", | ||
17 | "isopen": false, | 17 | "isopen": false, | ||
18 | "license_id": "notspecified", | 18 | "license_id": "notspecified", | ||
19 | "license_title": "License not specified", | 19 | "license_title": "License not specified", | ||
20 | "maintainer": null, | 20 | "maintainer": null, | ||
21 | "maintainer_email": null, | 21 | "maintainer_email": null, | ||
22 | "metadata_created": "2021-09-16T08:11:53.798306", | 22 | "metadata_created": "2021-09-16T08:11:53.798306", | ||
t | 23 | "metadata_modified": "2022-04-26T13:53:55.782877", | t | 23 | "metadata_modified": "2022-04-26T13:55:24.904518", |
24 | "name": "malawi-integrated-hiv-program-report-2012-q4", | 24 | "name": "malawi-integrated-hiv-program-report-2012-q4", | ||
25 | "notes": "This is the sixth quarterly HIV Program report after | 25 | "notes": "This is the sixth quarterly HIV Program report after | ||
26 | implementation of the 2011 Integrated Clinical\r\nHIV Guidelines in | 26 | implementation of the 2011 Integrated Clinical\r\nHIV Guidelines in | ||
27 | July 2011. A summary of the key achievements between __October and | 27 | July 2011. A summary of the key achievements between __October and | ||
28 | December\r\n2012__ is provided below:\r\n\r\n\u2022 Scale-up of | 28 | December\r\n2012__ is provided below:\r\n\r\n\u2022 Scale-up of | ||
29 | integrated HIV services had reached the following number of | 29 | integrated HIV services had reached the following number of | ||
30 | sites:\r\n\r\n __825__ static (607 within and 218 outside of health | 30 | sites:\r\n\r\n __825__ static (607 within and 218 outside of health | ||
31 | facilities) and 534 outreach HTC sites\r\n\r\n __651__(static) ART | 31 | facilities) and 534 outreach HTC sites\r\n\r\n __651__(static) ART | ||
32 | sites\r\n\r\n __585__PMTCT sites (Option B+)\r\n\r\n __577__ | 32 | sites\r\n\r\n __585__PMTCT sites (Option B+)\r\n\r\n __577__ | ||
33 | Pre-ART sites\r\n\r\n __579__ sites with HIV-exposed child | 33 | Pre-ART sites\r\n\r\n __579__ sites with HIV-exposed child | ||
34 | follow-up\r\n\r\n\u2022 __378,560__ persons were tested and counselled | 34 | follow-up\r\n\r\n\u2022 __378,560__ persons were tested and counselled | ||
35 | for HIV and __33,718 (9%)__ were HIV positive;\r\n__143,906 (38%)__ | 35 | for HIV and __33,718 (9%)__ were HIV positive;\r\n__143,906 (38%)__ | ||
36 | people tested for the first time.\r\n\r\n\u2022 __111,503 (68%)__ of | 36 | people tested for the first time.\r\n\r\n\u2022 __111,503 (68%)__ of | ||
37 | 163,510 women at ANC had their HIV status ascertained; __9,891 (9%)__ | 37 | 163,510 women at ANC had their HIV status ascertained; __9,891 (9%)__ | ||
38 | of\r\nthese were HIV positive. __117,730 (88%)__ of 132,755 women at | 38 | of\r\nthese were HIV positive. __117,730 (88%)__ of 132,755 women at | ||
39 | maternity had their HIV status\r\nascertained; __9,647 (8%)__ of these | 39 | maternity had their HIV status\r\nascertained; __9,647 (8%)__ of these | ||
40 | were HIV positive.\r\n\r\n\u2022 24,168 patients started ART during | 40 | were HIV positive.\r\n\r\n\u2022 24,168 patients started ART during | ||
41 | this quarter; this is a further decrease from the previous\r\nquarter | 41 | this quarter; this is a further decrease from the previous\r\nquarter | ||
42 | (26,909). Some of this decline was probably due to a shortage of HIV | 42 | (26,909). Some of this decline was probably due to a shortage of HIV | ||
43 | test kits.\r\n\u2022 404,905 patients were alive and on ART by end of | 43 | test kits.\r\n\u2022 404,905 patients were alive and on ART by end of | ||
44 | December 2012; 72,612 (19%) of 376,094\r\non first line adult regimens | 44 | December 2012; 72,612 (19%) of 376,094\r\non first line adult regimens | ||
45 | were on ART regimen 5A (tenofovir / lamivudine / efavirenz)\r\n\u2022 | 45 | were on ART regimen 5A (tenofovir / lamivudine / efavirenz)\r\n\u2022 | ||
46 | 80% of adults and 81% of children were retained alive on ART at 12 | 46 | 80% of adults and 81% of children were retained alive on ART at 12 | ||
47 | months after ART\r\ninitiation.\r\n\u2022 A total of 10,882 HIV | 47 | months after ART\r\ninitiation.\r\n\u2022 A total of 10,882 HIV | ||
48 | positive pregnant women were on ART: 4,211 (39%) of these | 48 | positive pregnant women were on ART: 4,211 (39%) of these | ||
49 | were\r\nalready on ART when getting pregnant and 6,671 (61%) started | 49 | were\r\nalready on ART when getting pregnant and 6,671 (61%) started | ||
50 | ART during\r\npregnancy/delivery. 6,349 (95%) of pregnant women | 50 | ART during\r\npregnancy/delivery. 6,349 (95%) of pregnant women | ||
51 | started ART due to Option B+ (in WHO\r\nclinical stage 1 or 2) and 322 | 51 | started ART due to Option B+ (in WHO\r\nclinical stage 1 or 2) and 322 | ||
52 | (5%) due to a low CD4 count and/or WHO clinical stage 3 or | 52 | (5%) due to a low CD4 count and/or WHO clinical stage 3 or | ||
53 | 4.\r\n\u2022 An additional 2,297 breastfeeding women started ART due | 53 | 4.\r\n\u2022 An additional 2,297 breastfeeding women started ART due | ||
54 | to Option B+ (in WHO clinical\r\nstage 1 or 2).\r\n\u2022 5,701 (84%) | 54 | to Option B+ (in WHO clinical\r\nstage 1 or 2).\r\n\u2022 5,701 (84%) | ||
55 | of 6,815 women started under Option B+ were retained at 6 months after | 55 | of 6,815 women started under Option B+ were retained at 6 months after | ||
56 | ART\r\ninitiation (6-month retention outcomes were missing for 1,348 | 56 | ART\r\ninitiation (6-month retention outcomes were missing for 1,348 | ||
57 | women registered, mainly at\r\nsites with electronic data | 57 | women registered, mainly at\r\nsites with electronic data | ||
58 | systems).\r\n\u2022 9,082 (8%) of infants discharged alive from | 58 | systems).\r\n\u2022 9,082 (8%) of infants discharged alive from | ||
59 | maternity were known to be HIV exposed, 8,174\r\n(90%) of these | 59 | maternity were known to be HIV exposed, 8,174\r\n(90%) of these | ||
60 | received ARV prophylaxis. 5,397 (59%) were enrolled in exposed child | 60 | received ARV prophylaxis. 5,397 (59%) were enrolled in exposed child | ||
61 | followup\r\nbefore age 2 months.\r\n\u2022 A total of 11,156 HIV | 61 | followup\r\nbefore age 2 months.\r\n\u2022 A total of 11,156 HIV | ||
62 | exposed children and 8,774 pre-ART patients enrolled for follow-up | 62 | exposed children and 8,774 pre-ART patients enrolled for follow-up | ||
63 | in\r\nHIV Care Clinics (HCC) during this quarter.\r\n\u2022 658 health | 63 | in\r\nHIV Care Clinics (HCC) during this quarter.\r\n\u2022 658 health | ||
64 | workers were trained in the new integrated PMTCT/ART curriculum during | 64 | workers were trained in the new integrated PMTCT/ART curriculum during | ||
65 | Q4\r\n2012, bringing the total number trained in the 2011 guidelines | 65 | Q4\r\n2012, bringing the total number trained in the 2011 guidelines | ||
66 | to 5,297. 112 District\r\nPMTCT/ART coordinators were trained in | 66 | to 5,297. 112 District\r\nPMTCT/ART coordinators were trained in | ||
67 | developing plans for Elimination of Mother to\r\nChild | 67 | developing plans for Elimination of Mother to\r\nChild | ||
68 | Transmission.\r\n\u2022 30 TB Officers in the SE Zone were trained in | 68 | Transmission.\r\n\u2022 30 TB Officers in the SE Zone were trained in | ||
69 | ART/TB management.\r\n\u2022 60 HTC Counsellors received training in | 69 | ART/TB management.\r\n\u2022 60 HTC Counsellors received training in | ||
70 | collecting dried blood spot specimens for Early\r\nInfant Diagnosis | 70 | collecting dried blood spot specimens for Early\r\nInfant Diagnosis | ||
71 | (EID).\r\n\u2022 100 facilities received mentoring for HIV Exposed | 71 | (EID).\r\n\u2022 100 facilities received mentoring for HIV Exposed | ||
72 | Child Follow-Up and EID specimen\r\ncollection.\r\n\u2022 598 Health | 72 | Child Follow-Up and EID specimen\r\ncollection.\r\n\u2022 598 Health | ||
73 | workers at 92 facilities in the SE Zone and 227 health workers and | 73 | workers at 92 facilities in the SE Zone and 227 health workers and | ||
74 | support staff\r\nat 33 facilities in the N Zone received clinical | 74 | support staff\r\nat 33 facilities in the N Zone received clinical | ||
75 | mentoring in provision of PMTCT/ART.", | 75 | mentoring in provision of PMTCT/ART.", | ||
76 | "num_resources": 1, | 76 | "num_resources": 1, | ||
77 | "num_tags": 1, | 77 | "num_tags": 1, | ||
78 | "organization": { | 78 | "organization": { | ||
79 | "approval_status": "approved", | 79 | "approval_status": "approved", | ||
80 | "created": "2021-10-14T11:02:35.234558", | 80 | "created": "2021-10-14T11:02:35.234558", | ||
81 | "description": "The Department of HIV & AIDS (DHA) was established | 81 | "description": "The Department of HIV & AIDS (DHA) was established | ||
82 | in 2001, initially as a unit in the Department of Clinical Services, | 82 | in 2001, initially as a unit in the Department of Clinical Services, | ||
83 | to coordinate the biomedical HIV Program in Malawi. The department now | 83 | to coordinate the biomedical HIV Program in Malawi. The department now | ||
84 | carries responsibility for various HIV related programs including: | 84 | carries responsibility for various HIV related programs including: | ||
85 | sexually transmitted infections (STIs), prevention of mother to child | 85 | sexually transmitted infections (STIs), prevention of mother to child | ||
86 | transmission of HIV (PMTCT), and national voluntary male medical | 86 | transmission of HIV (PMTCT), and national voluntary male medical | ||
87 | circumcision program (VMMC). All these HIV program sub-sections are | 87 | circumcision program (VMMC). All these HIV program sub-sections are | ||
88 | linked to one robust monitoring and evaluation sub-section in the HIV | 88 | linked to one robust monitoring and evaluation sub-section in the HIV | ||
89 | and AIDS Department which technically operates under the Central | 89 | and AIDS Department which technically operates under the Central | ||
90 | Monitoring and Evaluation Department (CMED) of the Ministry of | 90 | Monitoring and Evaluation Department (CMED) of the Ministry of | ||
91 | Health.", | 91 | Health.", | ||
92 | "id": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", | 92 | "id": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", | ||
93 | "image_url": | 93 | "image_url": | ||
94 | 2022-04-18-074318.527302WhatsApp-Image-2022-04-18-at-9.42.07-AM.jpeg", | 94 | 2022-04-18-074318.527302WhatsApp-Image-2022-04-18-at-9.42.07-AM.jpeg", | ||
95 | "is_organization": true, | 95 | "is_organization": true, | ||
96 | "name": "dha", | 96 | "name": "dha", | ||
97 | "state": "active", | 97 | "state": "active", | ||
98 | "title": "Department of HIV & AIDS and Viral Hepatitis", | 98 | "title": "Department of HIV & AIDS and Viral Hepatitis", | ||
99 | "type": "organization" | 99 | "type": "organization" | ||
100 | }, | 100 | }, | ||
101 | "owner_org": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", | 101 | "owner_org": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", | ||
102 | "private": false, | 102 | "private": false, | ||
103 | "program_area": "Care and Treatment", | 103 | "program_area": "Care and Treatment", | ||
104 | "relationships_as_object": [], | 104 | "relationships_as_object": [], | ||
105 | "relationships_as_subject": [], | 105 | "relationships_as_subject": [], | ||
106 | "resources": [ | 106 | "resources": [ | ||
107 | { | 107 | { | ||
108 | "cache_last_updated": null, | 108 | "cache_last_updated": null, | ||
109 | "cache_url": null, | 109 | "cache_url": null, | ||
110 | "created": "2022-03-23T19:55:47.446798", | 110 | "created": "2022-03-23T19:55:47.446798", | ||
111 | "description": "", | 111 | "description": "", | ||
112 | "format": "PDF", | 112 | "format": "PDF", | ||
113 | "hash": "", | 113 | "hash": "", | ||
114 | "id": "7f3ba4ca-40c4-4baa-92fe-9317b9945f6f", | 114 | "id": "7f3ba4ca-40c4-4baa-92fe-9317b9945f6f", | ||
115 | "last_modified": "2022-04-05T00:56:38.282373", | 115 | "last_modified": "2022-04-05T00:56:38.282373", | ||
116 | "lfs_prefix": | 116 | "lfs_prefix": | ||
117 | "dha/malawi-integrated-hiv-program-report-2012-q4", | 117 | "dha/malawi-integrated-hiv-program-report-2012-q4", | ||
118 | "metadata_modified": "2022-04-05T00:56:38.294202", | 118 | "metadata_modified": "2022-04-05T00:56:38.294202", | ||
119 | "mimetype": "application/pdf", | 119 | "mimetype": "application/pdf", | ||
120 | "mimetype_inner": null, | 120 | "mimetype_inner": null, | ||
121 | "name": "malawi-integrated-hiv-program-report-2012-q4", | 121 | "name": "malawi-integrated-hiv-program-report-2012-q4", | ||
122 | "package_id": "392167b0-d865-4262-b070-c0b0e45b721b", | 122 | "package_id": "392167b0-d865-4262-b070-c0b0e45b721b", | ||
123 | "position": 0, | 123 | "position": 0, | ||
124 | "resource_type": null, | 124 | "resource_type": null, | ||
125 | "sha256": | 125 | "sha256": | ||
126 | "4e982db7be9e944088e3948624ae30aba42fbe1b62e57baafb8372aa77a3fe8a", | 126 | "4e982db7be9e944088e3948624ae30aba42fbe1b62e57baafb8372aa77a3fe8a", | ||
127 | "size": 1853519, | 127 | "size": 1853519, | ||
128 | "state": "active", | 128 | "state": "active", | ||
129 | "url": | 129 | "url": | ||
130 | 17b9945f6f/download/malawi-integrated-hiv-program-report-2012-q4.pdf", | 130 | 17b9945f6f/download/malawi-integrated-hiv-program-report-2012-q4.pdf", | ||
131 | "url_type": "upload" | 131 | "url_type": "upload" | ||
132 | } | 132 | } | ||
133 | ], | 133 | ], | ||
134 | "state": "active", | 134 | "state": "active", | ||
135 | "tags": [ | 135 | "tags": [ | ||
136 | { | 136 | { | ||
137 | "display_name": "Report", | 137 | "display_name": "Report", | ||
138 | "id": "37e5a5df-a993-4d3f-8c9c-73c418c30f0f", | 138 | "id": "37e5a5df-a993-4d3f-8c9c-73c418c30f0f", | ||
139 | "name": "Report", | 139 | "name": "Report", | ||
140 | "state": "active", | 140 | "state": "active", | ||
141 | "vocabulary_id": null | 141 | "vocabulary_id": null | ||
142 | } | 142 | } | ||
143 | ], | 143 | ], | ||
144 | "title": "Malawi Integrated HIV Program Report 2012 Q4", | 144 | "title": "Malawi Integrated HIV Program Report 2012 Q4", | ||
145 | "type": "dataset", | 145 | "type": "dataset", | ||
146 | "url": null, | 146 | "url": null, | ||
147 | "version": null, | 147 | "version": null, | ||
148 | "year": "2012" | 148 | "year": "2012" | ||
149 | } | 149 | } |